NEW YORK (GenomeWeb News) – Beckman Coulter this week set a preliminary 2010 guidance for adjusted earnings per share of between $4.40 and $4.55. According to Thomas Weisel Partners analyst Peter Lawson, the guidance is below analysts' consensus estimate of $4.56.

"While initial 2010 guidance was below consensus, we believe management is maintaining a conservative outlook on the Olympus synergies and economic conditions," he wrote in a research note published Thursday evening.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.